These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

411 related items for PubMed ID: 11220492

  • 1. 5-HT1A receptor agonists buspirone and gepirone attenuate apomorphine-induced aggressive behaviour in adult male Wistar rats.
    Pruus K, Skrebuhhova-Malmros T, Rudissaar R, Matto V, Allikmets L.
    J Physiol Pharmacol; 2000 Dec; 51(4 Pt 2):833-46. PubMed ID: 11220492
    [Abstract] [Full Text] [Related]

  • 2. Selective antiaggressive effects of alnespirone in resident-intruder test are mediated via 5-hydroxytryptamine1A receptors: A comparative pharmacological study with 8-hydroxy-2-dipropylaminotetralin, ipsapirone, buspirone, eltoprazine, and WAY-100635.
    de Boer SF, Lesourd M, Mocaer E, Koolhaas JM.
    J Pharmacol Exp Ther; 1999 Mar; 288(3):1125-33. PubMed ID: 10027850
    [Abstract] [Full Text] [Related]

  • 3. Differential induction of 5-HT1A-mediated responses in vivo by three chemically dissimilar 5-HT1A agonists.
    Scott PA, Chou JM, Tang H, Frazer A.
    J Pharmacol Exp Ther; 1994 Jul; 270(1):198-208. PubMed ID: 8035316
    [Abstract] [Full Text] [Related]

  • 4. S 15535, a novel benzodioxopiperazine ligand of serotonin (5-HT)1A receptors: II. Modulation of hippocampal serotonin release in relation to potential anxiolytic properties.
    Millan MJ, Hjorth S, Samanin R, Schreiber R, Jaffard R, De Ladonchamps B, Veiga S, Goument B, Peglion JL, Spedding M, Brocco M.
    J Pharmacol Exp Ther; 1997 Jul; 282(1):148-61. PubMed ID: 9223550
    [Abstract] [Full Text] [Related]

  • 5. Reversal of haloperidol-induced tardive vacuous chewing movements and supersensitive somatodendritic serotonergic response by buspirone in rats.
    Haleem DJ, Samad N, Haleem MA.
    Pharmacol Biochem Behav; 2007 May; 87(1):115-21. PubMed ID: 17498786
    [Abstract] [Full Text] [Related]

  • 6. Indorenate produces antidepressant-like actions in the rat forced swimming test via 5-HT1A receptors.
    Martínez-Mota L, Estrada-Camarena E, López-Rubalcava C.
    Psychopharmacology (Berl); 2002 Dec; 165(1):60-6. PubMed ID: 12474119
    [Abstract] [Full Text] [Related]

  • 7. Pharmacological characterization of in vivo properties of putative mixed 5-HT1A agonist/5-HT2A/2C antagonist anxiolytics. I. Antipunishment effects in the pigeon.
    Kleven MS, Koek W.
    J Pharmacol Exp Ther; 1996 Feb; 276(2):388-97. PubMed ID: 8632301
    [Abstract] [Full Text] [Related]

  • 8. Facilitation and inhibition of male rat ejaculatory behaviour by the respective 5-HT1A and 5-HT1B receptor agonists 8-OH-DPAT and anpirtoline, as evidenced by use of the corresponding new and selective receptor antagonists NAD-299 and NAS-181.
    Hillegaart V, Ahlenius S.
    Br J Pharmacol; 1998 Dec; 125(8):1733-43. PubMed ID: 9886765
    [Abstract] [Full Text] [Related]

  • 9. In vitro and in vivo characterization of F-97013-GD, a partial 5-HT1A agonist with antipsychotic- and antiparkinsonian-like properties.
    Zazpe A, Artaiz I, Innerárity A, Del Olmo E, Castro E, Labeaga L, Pazos A, Orjales A.
    Neuropharmacology; 2006 Jul; 51(1):129-40. PubMed ID: 16643965
    [Abstract] [Full Text] [Related]

  • 10. Similar pharmacological properties of 8-OH-DPAT and alnespirone (S 20499) at dopamine receptors: comparison with buspirone.
    Protais P, Lesourd M, Comoy E.
    Eur J Pharmacol; 1998 Jul 10; 352(2-3):179-87. PubMed ID: 9716353
    [Abstract] [Full Text] [Related]

  • 11. Effect of the postsynaptic 5-HT1A receptor antagonist MM-77 on stressed mice treated with 5-HT1A receptor agents.
    Alfredo BA, Ofir P.
    Eur J Pharmacol; 2005 Jan 31; 508(1-3):155-8. PubMed ID: 15680266
    [Abstract] [Full Text] [Related]

  • 12. Co-administration of fluoxetine and WAY100635 improves short-term memory function.
    Fernández-Pérez S, Pache DM, Sewell RD.
    Eur J Pharmacol; 2005 Oct 17; 522(1-3):78-83. PubMed ID: 16214127
    [Abstract] [Full Text] [Related]

  • 13. 5-HT1A and 5-HT1B receptor agonists and aggression: a pharmacological challenge of the serotonin deficiency hypothesis.
    de Boer SF, Koolhaas JM.
    Eur J Pharmacol; 2005 Dec 05; 526(1-3):125-39. PubMed ID: 16310183
    [Abstract] [Full Text] [Related]

  • 14. Effect of yokukansan, a traditional Japanese medicine, on social and aggressive behaviour of para-chloroamphetamine-injected rats.
    Kanno H, Sekiguchi K, Yamaguchi T, Terawaki K, Yuzurihara M, Kase Y, Ikarashi Y.
    J Pharm Pharmacol; 2009 Sep 05; 61(9):1249-56. PubMed ID: 19703376
    [Abstract] [Full Text] [Related]

  • 15. Cellular and behavioral effects of 5-HT1A receptor agonist 8-OH-DPAT in a rat model of levodopa-induced motor complications.
    Ba M, Kong M, Ma G, Yang H, Lu G, Chen S, Liu Z.
    Brain Res; 2007 Jan 05; 1127(1):177-84. PubMed ID: 17113046
    [Abstract] [Full Text] [Related]

  • 16. Sex difference in the feeding responses of non-deprived rats to the 5-HT1A agonists 8-OH-DPAT and gepirone.
    Ebenezer IS, Tite R.
    Methods Find Exp Clin Pharmacol; 1994 Mar 05; 16(2):91-6. PubMed ID: 8007747
    [Abstract] [Full Text] [Related]

  • 17. Modification of sexual behavior of Long-Evans male rats by drugs acting on the 5-HT1A receptor.
    Rehman J, Kaynan A, Christ G, Valcic M, Maayani S, Melman A.
    Brain Res; 1999 Mar 13; 821(2):414-25. PubMed ID: 10064829
    [Abstract] [Full Text] [Related]

  • 18. Full and partial 5-HT1A receptor agonists disrupt learning and performance in rats.
    Winsauer PJ, Rodriguez FH, Cha AE, Moerschbaecher JM.
    J Pharmacol Exp Ther; 1999 Jan 13; 288(1):335-47. PubMed ID: 9862788
    [Abstract] [Full Text] [Related]

  • 19. Involvement of 5-hydroxytryptamine1A receptors in Delta9-tetrahydrocannabinol-induced catalepsy-like immobilization in mice.
    Egashira N, Matsuda T, Koushi E, Mishima K, Iwasaki K, Shoyama Y, Fujiwara M.
    Eur J Pharmacol; 2006 Nov 21; 550(1-3):117-22. PubMed ID: 17022969
    [Abstract] [Full Text] [Related]

  • 20. Tandospirone, a 5-HT1A agonist, ameliorates movement disorder via non-dopaminergic systems in rats with unilateral 6-hydroxydopamine-generated lesions.
    Matsubara K, Shimizu K, Suno M, Ogawa K, Awaya T, Yamada T, Noda T, Satomi M, Ohtaki K, Chiba K, Tasaki Y, Shiono H.
    Brain Res; 2006 Sep 27; 1112(1):126-33. PubMed ID: 16884702
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.